SC83288 is a clinical development candidate for the treatment of severe malaria.
Pegoraro S, Duffey M, Otto TD, Wang Y, Rösemann R, Baumgartner R, Fehler SK, Lucantoni L, Avery VM, Moreno-Sabater A, Mazier D, Vial HJ, Strobl S, Sanchez CP, Lanzer M.
Pegoraro S, et al. Among authors: strobl s.
Nat Commun. 2017 Jan 31;8:14193. doi: 10.1038/ncomms14193.
Nat Commun. 2017.
PMID: 28139658
Free PMC article.